Yeah,I too was disappointed with the small cohort, but I can understand the complexities of recruiting suitable candidates for trialing a novel drug. The main thing is that they were able to extract meaningful data and demonstrate a mechanism of action.
I think recruiting issues have been addressed for Phase 2b. The 8 - 10 dogs should come through much quicker than before. With the refined dosage regime I would expect 100% progression free survival and perhaps even notable reductions in tumor burdens.
If we attain these sort of results, it will be enough evidence to advance to a large scale Phase 3 with perhaps hundreds of dogs. But we won't have to do it on our own. I reckon the current trial will be closely monitored by a number of interested parties that may or may not include "Vet Major".
Cheers, Thrifty
- Forums
- ASX - By Stock
- PAA
- Ann: Appendix 4C and Quarterly Update
Ann: Appendix 4C and Quarterly Update, page-63
-
-
- There are more pages in this discussion • 44 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAA (ASX) to my watchlist
|
|||||
Last
17.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $85.12M |
Open | High | Low | Value | Volume |
18.0¢ | 18.0¢ | 17.0¢ | $141.2K | 801.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
11 | 537419 | 17.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
18.0¢ | 140000 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
11 | 537419 | 0.170 |
5 | 157060 | 0.165 |
9 | 476304 | 0.160 |
6 | 336734 | 0.155 |
8 | 225333 | 0.150 |
Price($) | Vol. | No. |
---|---|---|
0.180 | 140000 | 3 |
0.185 | 427553 | 5 |
0.190 | 720215 | 6 |
0.195 | 752882 | 12 |
0.200 | 297726 | 10 |
Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
Featured News
PAA (ASX) Chart |